Advertisement
UK markets close in 3 hours 56 minutes
  • FTSE 100

    8,390.96
    +36.91 (+0.44%)
     
  • FTSE 250

    20,532.89
    +40.90 (+0.20%)
     
  • AIM

    781.99
    +2.16 (+0.28%)
     
  • GBP/EUR

    1.1617
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2464
    -0.0034 (-0.27%)
     
  • Bitcoin GBP

    48,917.39
    -1,039.28 (-2.08%)
     
  • CMC Crypto 200

    1,315.35
    +15.25 (+1.17%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CRUDE OIL

    79.63
    +0.64 (+0.81%)
     
  • GOLD FUTURES

    2,319.10
    -3.20 (-0.14%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • DAX

    18,583.67
    +85.29 (+0.46%)
     
  • CAC 40

    8,142.95
    +11.54 (+0.14%)
     

A Licensing Agreement Won't Protect This Biotech From A Takeover

A Licensing Agreement Won't Protect This Biotech From A Takeover

Puma's licensing agreement for breast cancer drug Nerlynx won't inhibit takeover interest for Puma, an analyst said Tuesday.